Table 1 Baseline characteristics of study cohorts by sociodemographic status and comorbidity in Taiwan
Non-diabetes (%) ( N =166 850) | Type 2 diabetes (%) ( N =166 850) | Standardised mean difference | |
|---|---|---|---|
Sex | |||
Female | 74 148 (44.44%) | 74 148 (44.44%) | 0.00 |
Male | 92 702 (55.56%) | 92 702 (55.56%) | 0.00 |
Age, mean (s.d.) | 50.47 (12.07) | 50.71 (11.80) | −0.02 |
Urbanisation degree | |||
High density urban area | 46 967 (28.48%) | 47 128 (28.61%) | 0.00 |
Medium density urban area | 47 521 (28.81%) | 48 861 (29.66%) | −0.02 |
Newly developed area | 28 844 (17.49%) | 28 045 (17.02%) | 0.01 |
General area | 24 458 (14.83%) | 24 262 (14.73%) | 0.00 |
Ageing society area | 3440 (2.09%) | 3655 (2.22%) | −0.01 |
Rural area | 7264 (4.40%) | 6773 (4.11%) | 0.01 |
Non-developed area | 6437 (3.90%) | 6028 (3.66%) | 0.01 |
Insurance premium | |||
INS-AMT<19 200 | 41 195 (24.69%) | 44 469 (26.65%) | −0.04 |
19 200≦INS-AMT | 125 655 (75.31%) | 122 381 (73.35%) | 0.04 |
Comorbidity | |||
Acute alcoholic hepatitis | 19 855 (11.90%) | 37 973 (22.76%) | −0.29 |
Acute hepatitis | 177 (0.11%) | 91 (0.05%) | 0.02 |
Acute pancreatitis | 186 (0.11%) | 252 (0.15%) | −0.01 |
Alcoholic fatty liver | 19 864 (11.91%) | 37 997 (22.77%) | −0.29 |
Non-alcoholic fatty liver disease | 571 (0.34%) | 391 (0.23%) | 0.02 |
Alcoholic cirrhosis of liver | 19 837 (11.89%) | 37 990 (22.77%) | −0.29 |
Cholelithiasis | 1126 (0.67%) | 407 (0.24%) | 0.06 |
Chronic pancreatitis | 37 (0.02%) | 245 (0.15%) | −0.04 |
Morbid obesity | 113 (0.07%) | 605 (0.36%) | −0.06 |
Alcohol dependence syndrome | 317 (0.19%) | 314 (0.19%) | 0.00 |
Pseudocyst of pancreas | 6 (0.00%) | 13 (0.01%) | −0.01 |
Jaundice | 62 (0.04%) | 25 (0.01%) | 0.02 |
Hepatitis B | 1981 (1.19%) | 2248 (1.35%) | −0.01 |
Hepatitis C | 1774 (1.06%) | 2141 (1.28%) | −0.02 |
Cholecystitis | 3740 (2.24%) | 1953 (1.17%) | 0.08 |
Cholangitis | 143 (0.09%) | 43 (0.03%) | 0.03 |
Gastric ulcer | 41 906 (25.12%) | 27 391 (16.42%) | 0.21 |
Duodenal ulcer | 41 976 (25.16%) | 27 408 (16.43%) | 0.22 |
